3BBLACKBIO vs ANUHPHR: Stock Comparison

3B Blackbio DX Ltd vs Anuh Pharma Limited

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

3B Blackbio DX Ltd is the larger company by market capitalisation. 3B Blackbio DX Ltd shows a lower P/E, a higher ROE and a higher ROCE, while Anuh Pharma Limited shows a higher dividend yield, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of 3B Blackbio DX Ltd and Anuh Pharma Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, 3BBLACKBIO is more favourable on 9 of 13 scored metrics and ANUHPHR on 4These counts are context-free and are not an overall rating.

Key Differences

Market Cap
3BBLACKBIO is the larger company
₹1,099 Cr vs ₹793 Cr
P/E Ratio
3BBLACKBIO has a lower P/E
18.71x vs 19.37x
P/B Ratio
ANUHPHR has a lower P/B
2.26x vs 3.38x
EPS
3BBLACKBIO has higher earnings per share
₹68.3 vs ₹4.1
Dividend Yield
ANUHPHR has a higher dividend yield
1.87% vs 0.34%
Revenue Growth (TTM YoY)
ANUHPHR has faster revenue growth
2% vs 0%
EPS Growth (TTM YoY)
3BBLACKBIO has faster EPS growth
0% vs -6%
Qtr Sales Growth
3BBLACKBIO has stronger quarterly sales growth
57.5% vs 2.01%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

Metric3BBLACKBIOANUHPHR
SectorHealthcare
IndustryPharmaceuticals

Price

Metric3BBLACKBIOANUHPHR
Live Price₹1,278.1₹79.07
Day Change0.19%-0.48%
Volume4,08617,342
52-Week High₹1,441.5₹101.7
52-Week Low₹1,085₹67
Distance from 52W High-11.34%-22.25%

Valuation

Metric3BBLACKBIOANUHPHR
Market Cap₹1,099 Cr₹793 Cr
P/E Ratio18.71x19.37x
P/B Ratio3.38x2.26x
EPS₹68.3₹4.1
Book Value₹378₹35.28
Dividend Yield0.34%1.87%

Growth

Metric3BBLACKBIOANUHPHR
Revenue Growth (TTM YoY)0%2%
EPS Growth (TTM YoY)0%-6%
Qtr Sales Growth57.5%2.01%
Qtr Profit Growth13.8%-6.26%

Profitability & Leverage

Metric3BBLACKBIOANUHPHR
ROE19.8%12.1%
ROCE25.5%15.9%
Net Margin42.23%5.32%
Operating Margin40%8%
Debt to Equity0.01x0x

Shareholding

As of Mar 2026 • change vs previous quarter
Metric3BBLACKBIOANUHPHR
Promoter Holding38.46%71.78% 0.02 pp
FII Holding2.57%0.05% 0.05 pp
DII Holding1.98% 0.1 pp0%
Public Holding54.51% 0.23 pp28.16% 0.02 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: 3B Blackbio DX Ltd and Anuh Pharma Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.